Research on the Mechanism of Pulsatilla Potentially Useful for the Treatment of Triple Negative Breast Cancer Based on Network Pharmacology

preprint OA: closed CC-BY-4.0
📄 Open PDF View at publisher

Abstract

Triple negative breast cancer is a very malignant type of breast cancer. Its age of onset is young and the prognosis is poor, which seriously threatens women's physical and mental health. Pulsatilla Chinensis is a common medicine in traditional Chinese medicine. Application of network pharmacology analysis found that the active ingredients in Pulsatilla can target Caspase-3, NOS3, etc. to exert anti-tumor effects. This discovery will provide new alternative drugs and potential methods for the treatment of triple-negative breast cancer.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-05-19T01:45:01.086888+00:00
unpaywall
last seen: 2026-08-16T06:22:10.609676+00:00
License: CC-BY-4.0